Chicago Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Chicago Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,000	Closed	-$8.17M	–	33
2025 Q4	$8.17M	Buy	+49,000	New	+$7.92M	5.56%	2

Chicago Capital Management's CDTX Position: Q1 2026 in Review

Chicago Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 49,000 shares — an estimated $8.17M sold.

Chicago Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $8.17M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Chicago Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Chicago Capital Management sold 49,000 Cidara Therapeutics shares in Q1 2026, an estimated $8.17M.
Chicago Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Chicago Capital Management's Cidara Therapeutics position peaked at $8.17M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Chicago Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.